268 related articles for article (PubMed ID: 17997115)
21. Does the inhalation device affect the bronchodilatory dose response curve of salbutamol in asthma and chronic obstructive pulmonary disease patients?
Broeders ME; Molema J; Hop WC; Vermue NA; Folgering HT
Eur J Clin Pharmacol; 2003 Sep; 59(5-6):449-55. PubMed ID: 12920494
[TBL] [Abstract][Full Text] [Related]
22. The bronchoprotective efficacy of salbutamol inhaled from a new metered-dose powder inhaler compared with a conventional pressurized metered-dose inhaler connected to a spacer.
Seppälä OP; Herrala J; Hedman J; Alanko K; Liipo K; Terho E; Pietinalho A; Nyholm JE; Nieminen MM
Respir Med; 1998 Mar; 92(3):578-83. PubMed ID: 9692126
[TBL] [Abstract][Full Text] [Related]
23. Salbutamol tolerance to bronchoprotection: course of onset.
Stewart SL; Martin AL; Davis BE; Cockcroft DW
Ann Allergy Asthma Immunol; 2012 Dec; 109(6):454-7. PubMed ID: 23176887
[TBL] [Abstract][Full Text] [Related]
24. [Comparison of the bronchodilator effect of salbutamol between pressure metered dosed inhaler and dry powder inhaler in patients with stable bronchial asthma].
Yoshimi Y; Fujimura M; Yasui M; Kasahara K; Nakao S
Arerugi; 2004 May; 53(5):502-7. PubMed ID: 15247530
[TBL] [Abstract][Full Text] [Related]
25. Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial.
Haney S; Hancox RJ
Respir Res; 2005 Sep; 6(1):107. PubMed ID: 16168062
[TBL] [Abstract][Full Text] [Related]
26. Reduced dose salbutamol in comparison with standard dosage for symptom relief in asthma.
Yates DH; Peters MJ; Keatings V; Thomas PS; Barnes PJ
Eur Respir J; 1995 Nov; 8(11):1847-51. PubMed ID: 8620950
[TBL] [Abstract][Full Text] [Related]
27. Differences in bronchodilating potency of salbutamol in Turbuhaler as compared with a pressurized metered-dose inhaler formulation in patients with reversible airway obstruction.
Löfdahl CG; Andersson L; Bondesson E; Carlsson LG; Friberg K; Hedner J; Hörnblad Y; Jemsby P; Källén A; Ullman A; Werner S; Svedmyr N
Eur Respir J; 1997 Nov; 10(11):2474-8. PubMed ID: 9426081
[TBL] [Abstract][Full Text] [Related]
28. Assessment of a relative therapeutic index between inhaled formoterol and salbuterol in asthma patients.
Rosenborg J; Larsson P; Rott Z; Böcskei C; Poczi M; Juhász G
Eur J Clin Pharmacol; 2002 Jul; 58(4):S61-7. PubMed ID: 12214580
[TBL] [Abstract][Full Text] [Related]
29. Comparative pharmacokinetics of salbutamol inhaled from a pressurized metered dose inhaler either alone or connected to a newly enhanced spacer design.
Ammari WG; Oriquat GA; Sanders M
Eur J Pharm Sci; 2020 Apr; 147():105304. PubMed ID: 32165316
[TBL] [Abstract][Full Text] [Related]
30. Comparison of powder and aerosol formulations of salmeterol in the treatment of asthma.
Wolfe J; Kreitzer S; Chervinsky P; Lawrence M; Wang Y; Reilly D; Davis S; Stahl E
Ann Allergy Asthma Immunol; 2000 Mar; 84(3):334-40. PubMed ID: 10752919
[TBL] [Abstract][Full Text] [Related]
31. Early lung absorption profile of non-CFC salbutamol via small and large volume plastic spacer devices.
Lipworth BJ; Clark DJ
Br J Clin Pharmacol; 1998 Jul; 46(1):45-8. PubMed ID: 9690948
[TBL] [Abstract][Full Text] [Related]
32. Salbutamol via Easyhaler is at least as effective as salbutamol via Turbuhaler in the treatment of histamine-induced bronchoconstriction.
Zetterström O; Lähelmä S; Keski-karhu J; Silvasti M; Ostling-kulling E; Ahonen A
Respir Med; 2000 Nov; 94(11):1097-102. PubMed ID: 11127498
[TBL] [Abstract][Full Text] [Related]
33. A Dose-Response Study Examining the Use of Methacholine Challenge to Demonstrate Local Therapeutic Equivalence of the Salmeterol Component of Generic Inhaled Fluticasone Propionate/Salmeterol Combination Products.
Allan R; Haughie S; Ahrens R; Singh S; Ward J
J Aerosol Med Pulm Drug Deliv; 2019 Dec; 32(6):352-363. PubMed ID: 31259673
[No Abstract] [Full Text] [Related]
34. A methacholine challenge dose-response study for development of a pharmacodynamic bioequivalence methodology for albuterol metered- dose inhalers.
Creticos PS; Adams WP; Petty BG; Lewis LD; Singh GJ; Khattignavong AP; Molzon JA; Martinez MN; Lietman PS; Williams RL
J Allergy Clin Immunol; 2002 Nov; 110(5):713-20. PubMed ID: 12417879
[TBL] [Abstract][Full Text] [Related]
35. Pilot study of bronchodilator response to inhaled albuterol delivered by metered-dose inhaler and a novel dry powder inhaler.
Kemp JP; Hill MR; Vaughan LM; Meltzer EO; Welch MJ; Ostrom NK
Ann Allergy Asthma Immunol; 1997 Oct; 79(4):322-6. PubMed ID: 9357377
[TBL] [Abstract][Full Text] [Related]
36. Equivalent bronchodilation with salbutamol given via pMDI or turbuhaler.
Mellén A; Arvidsson P; Palmqvist M; Lötvall J
Am J Respir Crit Care Med; 1999 May; 159(5 Pt 1):1663-5. PubMed ID: 10228142
[TBL] [Abstract][Full Text] [Related]
37. The Spacehaler for delivery of salbutamol: a comparison with the standard metered-dose inhaler plus Volumatic spacer device.
Gunawardena KA; Sohal T; Jones JI; Upchurch FC; Crompton GK
Respir Med; 1997 May; 91(5):311-6. PubMed ID: 9176650
[TBL] [Abstract][Full Text] [Related]
38. Equivalent therapeutic ratio of salbutamol given by Turbuhaler and Diskus.
Arvidsson P; Mellén A; Palmqvist M; Lötvall J
Respir Med; 2000 Jun; 94(6):574-7. PubMed ID: 10921762
[TBL] [Abstract][Full Text] [Related]
39. Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction.
van der Woude HJ; Boorsma M; Bergqvist PB; Winter TH; Aalbers R
Pulm Pharmacol Ther; 2004; 17(2):89-95. PubMed ID: 15123230
[TBL] [Abstract][Full Text] [Related]
40. Beta 2-agonists administered by a dry powder inhaler can be used in acute asthma.
Nana A; Youngchaiyud P; Maranetra N; Boe J; Löfdahl CG; Selroos O; Ståhl E
Respir Med; 1998 Feb; 92(2):167-72. PubMed ID: 9616507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]